Triple agonists add glucagon receptor activation, which: Increases resting energy expenditure by 8% to 12% (Jall et al., Diabetes Care 2024) Promotes hepatic fat oxidation and reduces steatosis May offset some of the lean mass loss seen with GLP-1 monotherapy (early signal, not yet confirmed in long-term trials) The weight loss ceiling for retatrutide appears to be 24% to 26% based on phase 3 data, though long-term real-world outcomes are not yet available
Zucchini noodles add volume without heavy carbs
Association between mutational subgroups, Warburg-subtypes, and survival in patients with colorectal cancer
And they can't see anything wrong
Fermented foods as a probiotic source Supplements are convenient, but fermented foods provide both probiotics and prebiotics in a food matrix that may enhance survival through the stomach
At this time, there is no cure for genetic hair loss